TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

TGA presentations given at the Complementary Medicines Australia - 2015 Quality Learning Seminar

29 June 2015

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation slides should not be relied upon in any way as representing a comprehensive description of regulatory requirements, (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation papers (slides), and (c) the industry slides (on the green Sponsor Information & Training Day templates) are the views of the listed speaker, and are not endorsed by TGA. They have been included here for the convenience of attendees and other interested in the content of the event, in the interest of completeness.

Sessions

3 June 2015

TGA's role in ensuring quality complementary medicines

Good manufacturing practices for complementary medicines

  • Presented by: Doreene Kohalmi, Senior Inspector, Manufacturing Quality Branch, Monitoring and Compliance Division
  • Presentation summary: This presentation provides an overview of GMP clearance application process, the TGA compliance risk framework, major deficiencies and manufacturing quality challenges.
  • Presentation: Good manufacturing practices for complementary medicines

Illegal products - what can be done?

  • Presented by: Larry Kelly, First Assistant Secretary, Monitoring and Compliance Division
  • Presentation summary: This presentation provides an outline to illegal products and what can be done including collaboration both domestically and internationally while ensuring quality is considered.
  • Presentation: Illegal products - what can be done?